Biolase Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Biolase Inc inventory turnover ratio, the Biolase Inc 's ability to sell and replace its inventory in the third quarter 2024, sequentially increased to 2.56 in the third quarter 2024, BIOL's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Biolase Inc in Sep 30 2024 quarter, has decreased to 143 days, compare to 150 days, in the Jun 30 2024 quarter.

Within Healthcare sector 172 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2024, to 943, from total ranking in the second quarter 2024 at 1324.

BIOL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Biolase Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BIOL Inventory Turnover Ratio	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter
Y / Y Inventory Growth	-28.6 %	-18.2 %	-36.58 %	-28.02 %	-15.85 %
Y / Y Cost of Sales Growth	-14.29 %	-25 %	-15.85 %	-5.6 %	-26.82 %
Inventory Turnover Ratio (TTM)	2.56	2.43	2.48	2.27	2.14
BIOL's Total Ranking	# 943	# 1324	# 1148	# 1169	# 1008
Average inventory processing period	142	150	147	161	170
Seq. Inventory Growth	-9.48 %	-3.27 %	-1.4 %	-17.3 %	3.71 %
Seq. Cost of Sales Growth	0 %	0 %	-39.21 %	41 %	-12.5 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 67
Healthcare Sector	# 173
Overall Market	# 943

Inventory Turnover Ratio Statistics
High	Average	Low
3.06	2.24	1.3
(Sep 30 2013)		(Sep 30 2020)

BIOL Company Profile >> Back to BIOL Efficiency Comparisons >> Compare BIOL Inventory Turnover Ratio to its Competitors

Financial Statements
Biolase Inc 's Inventories	$ 10 Millions	Visit BIOL's Balance sheet
Biolase Inc 's Cost of Revenues TTM	$ 28 Millions	Visit BIOL's Income Statement
What are BIOL's Sales?		Visit BIOL's Sales by Segment

Other Inventory Turnover Ratios
Biolase Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BIOL's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BIOL's Competitors
Inventory Turnover Ratio for BIOL's Suppliers
Inventory Turnover Ratio for BIOL's Customers

You may also want to know
BIOL's Sales Growth Rates	BIOL's Pe Price to earnings ratio	BIOL's Receivables Turnover Ratio	BIOL's Stock Quote
BIOL's Net Income Growth Rates	BIOL's Ps Price to Sales ratio	BIOL's Sales per Employee	BIOL's Asset Turnover Ratio
BIOL's Net Margin	BIOL's Pb Price to Book ratio	BIOL's Financial Strength Ratios	BIOL's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2024	Inventories at quarter ending Sep 30 2024
Lantheus Holdings Inc	7.65	$ 526.239 Millions	$ 69 Millions
Nutriband Inc	7.59	$ 1.383 Millions	$ 0 Millions
Carlisle Companies Incorporated	7.53	$ 3,106.300 Millions	$ 413 Millions
Castle Biosciences Inc	7.48	$ 56.445 Millions	$ 8 Millions
Jrsis Health Care Corp	7.30	$ 3.029 Millions	$ 0 Millions
Kewaunee Scientific Corporation	7.26	$ 146.000 Millions	$ 20 Millions
Eton Pharmaceuticals Inc	7.21	$ 13.042 Millions	$ 2 Millions
Charles River Laboratories International inc	7.19	$ 2,564.710 Millions	$ 357 Millions
23andme Holding Co	7.07	$ 102.000 Millions	$ 14 Millions
Collegium Pharmaceutical Inc	6.92	$ 224.115 Millions	$ 32 Millions
Bionexus Gene Lab Corp	6.91	$ 8.011 Millions	$ 1 Millions
Cardiff Lexington Corporation	6.78	$ 3.659 Millions	$ 1 Millions
Hims and Hers Health Inc	6.61	$ 234.655 Millions	$ 35 Millions
Fonar Corporation	6.52	$ 18.419 Millions	$ 3 Millions
Twist Bioscience Corporation	6.31	$ 179.625 Millions	$ 28 Millions
Acadia Pharmaceuticals Inc	6.29	$ 77.928 Millions	$ 12 Millions
Patterson Companies Inc	6.18	$ 5,193.000 Millions	$ 840 Millions
Bgm Group Ltd	5.97	$ 20.000 Millions	$ 3 Millions
Scorpius Holdings inc	5.88	$ 3.825 Millions	$ 1 Millions
Evolus Inc	5.87	$ 74.637 Millions	$ 13 Millions
Warby Parker Inc	5.87	$ 329.823 Millions	$ 56 Millions
Exact Sciences Corporation	5.76	$ 748.983 Millions	$ 130 Millions
Veracyte Inc	5.73	$ 106.084 Millions	$ 19 Millions
Avantor Inc	5.64	$ 4,533.000 Millions	$ 803 Millions
Adaptive Biotechnologies Corporation	5.57	$ 73.651 Millions	$ 13 Millions
Opko Health Inc	5.33	$ 325.798 Millions	$ 61 Millions
Cryoport inc	5.31	$ 130.502 Millions	$ 25 Millions
Medinotec Inc	5.30	$ 4.677 Millions	$ 1 Millions
Catalent Inc	5.23	$ 3,457.000 Millions	$ 661 Millions
T2 Biosystems Inc	5.15	$ 23.785 Millions	$ 5 Millions

Date modified: 2026-08-29T17:19:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.